Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2014-10-29FDA Approved: DONEPEZIL HYDROCHLORIDE — Original Application (ScieGen Pharmaceuticals, Inc.)
The FDA approved ScieGen Pharmaceuticals' original application for donepezil hydrochloride, a generic version of an Alzheimer’s disease ther…
-
CLINICAL_TRIALS trial_result · 2014-10-28Clinical Trial Update: A Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild-to-Moderate Alzheimer´s Disease [Phase 3]
Phase 3 trial evaluating IGIV 10% for mild-to-moderate Alzheimer's disease has been completed with results posted in 2014.
-
FDA approval · 2014-10-26FDA Approved: DONEPEZIL HYDROCHLORIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for donepezil hydrochloride (Rising Pharma Holdings, Inc.). This action indicates modifications to t…
-
CLINICAL_TRIALS trial_result · 2014-10-24Clinical Trial Update: Memantine Plus Es-citalopram in Elderly Depressed Patients With Cognitive Impairment [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial evaluated memantine in combination with escitalopram in elderly patients with mild cognitive impairment and…
-
CLINICAL_TRIALS trial_result · 2014-10-24Clinical Trial Update: The Use of EEG in Alzheimer's Disease, With and Without Scopolamine - A Pilot Study [NA]
A completed pilot study investigating EEG changes in Alzheimer's disease with and without scopolamine. It explored whether scopolamine influ…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-10-24Clinical Trial Update: Evaluating Cerebrospinal Fluid Biomarkers in Alzheimer's, Progressive Supranuclear Palsy Subjects, and Controls
The update presents results from a cerebrospinal fluid biomarker study in participants with Alzheimer's disease, progressive supranuclear pa…
-
CLINICAL_TRIALS withdrawal · 2014-10-23Clinical Trial Update: Evaluation of Electronic Florbetapir (18F) Interpretation Training in Japanese Physicians [NA]
A clinical trial evaluating electronic interpretation training for Florbetapir F-18 PET imaging in Japanese physicians was withdrawn.
-
CLINICAL_TRIALS trial_result · 2014-10-21Clinical Trial Update: Effects of Memantine on Magnetic Resonance (MR) Spectroscopy in Subjects at Risk for Alzheimer's Disease [Phase 4]
Phase 4 clinical trial update examining memantine's effects on MR spectroscopy in subjects at risk for Alzheimer's disease.
-
FDA label_change · 2014-10-15FDA Approved: NEURACEQ — Supplemental Application (Lantheus Biosciences Ltd.)
The FDA approved a supplemental application for NEURACEQ (florbetaben F-18), expanding labeling to support its use as a PET imaging agent to…
-
CLINICAL_TRIALS research · 2014-10-15Clinical Trial Update: Capacity Assessment in Persons With Alzheimer's Disease
This document reports an update on a clinical trial evaluating capacity assessment in people with Alzheimer's disease. It covers capacity to…
-
CLINICAL_TRIALS other · 2014-10-15Clinical Trial Update: Alzheimer Disease : Rehabilitation's Intervention at Home [NA]
Clinical trial update indicates the study on at-home rehabilitation for Alzheimer's disease has been terminated.
-
CLINICAL_TRIALS research · 2014-10-03Clinical Trial Update: The PACO Study ("Personnalité Alzheimer COmportement") [NA]
Clinical trial update for the PACO study (Personnalité Alzheimer COmportement) investigating Alzheimer's disease; status is currently UNKNOW…
-
CLINICAL_TRIALS trial_result · 2014-09-29Clinical Trial Update: Home Safety Clinical Trial for Alzheimer's Disease [Phase 1]
Phase 1 clinical trial evaluating a home safety intervention for individuals with Alzheimer's disease or dementia; the study is completed an…
-
CLINICAL_TRIALS trial_result · 2014-09-26Clinical Trial Update: Efficacy and Safety of Talsaclidine in Patients With Mild to Moderate Dementia of Alzheimer Type [Phase 2]
A Phase 2 study evaluating the efficacy and safety of talsaclidine in patients with mild to moderate Alzheimer's disease has completed. The …
-
CLINICAL_TRIALS trial_result · 2014-09-26Clinical Trial Update: Efficacy and Safety of Talsaclidine (Free Base) in Patients With Mild to Moderate Dementia of Alzheimer Type [Phase 2]
Phase 2 trial update evaluating the efficacy and safety of talsaclidine (free base) in patients with mild-to-moderate Alzheimer's disease. T…
-
CLINICAL_TRIALS trial_result · 2014-09-25Clinical Trial Update: A Study of Semagacestat for Alzheimer's Patients [Phase 3]
Phase 3 trial of semagacestat for Alzheimer's disease completed; results have been posted.
-
CLINICAL_TRIALS trial_result · 2014-09-25Clinical Trial Update: Effect of LY450139 on the Long Term Progression of Alzheimer's Disease [Phase 3]
Phase 3 trial of LY450139 (semagacestat) for Alzheimer's disease has completed; results were posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-09-25Clinical Trial Update: Effects of LY450139, on the Progression of Alzheimer's Disease as Compared With Placebo [Phase 3]
Phase 3 trial evaluating LY450139 versus placebo for progression in Alzheimer's disease; results have been posted after completion in 2014.
-
CLINICAL_TRIALS trial_result · 2014-09-25Clinical Trial Update: Minocycline in Patients With Alzheimer's Disease [Phase 2]
Phase 2 clinical trial update for minocycline in patients with Alzheimer's disease; results were posted in 2014 (2014-09-25).
-
CLINICAL_TRIALS trial_result · 2014-09-25Clinical Trial Update: Follow-up Trial to Assess the Long-term Safety and Tolerability of Talsaclidine in Patients With Mild to Moderate Dementia of the Alzheimer Type [Phase 2, Phase 3]
A Phase 2/3 follow-up trial evaluating the long-term safety and tolerability of talsaclidine in patients with Alzheimer's disease has been t…
-
CLINICAL_TRIALS research · 2014-09-23Clinical Trial Update: Cognitive Rehabilitation in Alzheimer's Disease [NA]
This entry reports a clinical trial update on cognitive rehabilitation for Alzheimer's disease, but provides no results and lists the trial …
-
CLINICAL_TRIALS trial_result · 2014-09-19Clinical Trial Update: A Multiple-dose Study of Gantenerumab in Japanese Alzheimer&Apos;s Disease Patients [Phase 1]
A Phase 1 multiple-dose study of gantenerumab in Japanese patients with Alzheimer's disease has completed.
-
EMA withdrawal · 2014-09-18EMA Withdrawn: Rivastigmine 3M Health Care Ltd (rivastigmine) — 3M Health Care Limited
EMA withdrew the rivastigmine product from 3M Health Care Limited, with the withdrawn status recorded for Alzheimer disease treatment.
-
CLINICAL_TRIALS trial_result · 2014-09-17Clinical Trial Update: Imaging Characteristics of Florbetapir 18F in Patients With Frontotemporal Dementia, Alzheimer's Disease and Normal Controls. [Phase 2]
Phase 2 clinical trial update evaluating imaging characteristics of florbetapir F-18 in Alzheimer's disease, frontotemporal dementia, and no…
-
CLINICAL_TRIALS trial_result · 2014-09-16Clinical Trial Update: ADNI: Alzheimer's Disease Neuroimaging Initiative
This record notes the completion of the ADNI Alzheimer's Disease Neuroimaging Initiative trial sponsored by the Alzheimer's Disease Cooperat…